MarketCapTrends
BMY
Bristol-Myers Squibb Company (BMY)
NYSE · Healthcare

Bristol-Myers Squibb Company Shareholder Equity 2007–2025

Bristol-Myers Squibb Company annual/quarterly shareholder equity history from 2008 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Bristol-Myers Squibb Company shareholder equity for the quarter ending December 31, 2025 were 18.47B, a 13.09% increase year-over-year.
  • Bristol-Myers Squibb Company shareholder equity for 2025 were 18.47B, a 13.09% increase from 2024.
  • Bristol-Myers Squibb Company shareholder equity for 2024 were 16.34B, a 44.50% decrease from 2023.
  • Bristol-Myers Squibb Company shareholder equity for 2023 were 29.43B, a 5.25% decrease from 2022.
  • Bristol-Myers Squibb Company shareholder equity for 2022 were 31.06B.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Bristol-Myers Squibb Company Annual Shareholder Equity (Millions of US $)
2025$18,473
2024$16,335
2023$29,430
2022$31,061
2021$35,946
2020$37,822
2019$51,598
2018$14,031
2017$11,741
2016$16,177
2015$14,266
2014$14,852
2013$15,154
2012$13,623
2011$15,956
Bristol-Myers Squibb Company Quarterly Shareholder Equity (Millions of US $)
2025-12-31$18,473
2024-12-31$16,335
2023-12-31$29,430
2022-12-31$31,061
2021-12-31$35,946
2020-12-31$37,822
2019-12-31$51,598
2018-12-31$14,031
2017-12-31$11,741
2016-12-31$16,177
2015-12-31$14,266
2014-12-31$14,852
2013-12-31$15,154
2012-12-31$13,623
2011-12-31$15,956
2010-12-31$15,713
2009-12-31$14,843
2008-12-31$12,241

Bristol-Myers Squibb Company Shareholder Equity — FAQ

Bristol-Myers Squibb Company (BMY) shareholder equity over the last 19 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see BMY's shareholder equity history?

The chart and table above show Bristol-Myers Squibb Company's shareholder equity by year and by quarter, including the growth rate.